Transcranial direct current stimulation combined with transcranial magnetic stimulation provides safe and more effective major depressive disorder treatment.

Many individuals have been told that their illness is "treatment resistant." However, this only means that they haven't ...

In a recent study, transcranial magnetic stimulation was found to be more effective than switching to a new medication for ...

It was approved by the FDA in 2008 to treat major depressive disorder, and it was recently approved for teens.

BrainsWay (BWAY) announced recent positive pilot data from an independent, third-party study conducted at Stanford University ...

Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced non-invasive treatment of brain ...

For the twenty-one million American adults experiencing major depressive disorder (MDD) annually, this FDA-cleared treatment ...

Brainsway ( (BWAY) ) has provided an announcement.

A new study has identified a distinct brain network connecting areas of atrophy associated with schizophrenia, offering a ...

Transcranial Magnetic Stimulation (TMS) is a non-invasive procedure that’s FDA cleared. The technology is not new. It’s been around since 2008, but Ascension just started offering it through a new ...

Neural activities were assessed via interruption effects induced by High-Definition transcranial direct current stimulation (HD-tDCS). Additionally, chronometric double-pulse transcranial magnetic ...

A new study led by investigators from Mass General Brigham has identified a unique brain network that links varied patterns ...